South East Essex End of Life and Hospice Services

Concepts

• health services
• south east essex
• rayleigh
• south east essex end of life and hospice services
• end of life and hospice services
• south east essex end of life
• hospice inpatient unit
• end of life care
• end of life
• community hospice setting

Location

South East Essex

Description

This is a voluntary ex ante transparency notice and is intended to provide notice of the Authority's intention to award a contract to deliver End of Life and Hospice Services covering the population of South East Essex, for a period of 24 months, from 1st April 2022 – 31st March 2024. This notice is made by the Contracting Authorities; NHS Castle Point and Rochford Clinical Commissioning Group and NHS Southend Clinical Commissioning Group (hereinafter referred to as “the Authority”) in compliance with their local standing financial instructions (SFIs). The aggregate contract value is forecasted at £1,863,788 (including VAT) over the two-year term, equating to £1,553,157 excluding VAT).

Total Quantity or Scope

This is a voluntary ex ante transparency notice and is intended to provide notice of the Authority's intention to award a contract to deliver End of Life / Hospice and associated Services covering the population of South East Essex, for a period of 24 months, from 1st April 2022 – 31st March 2024. … The services being awarded under the contract include specialist palliative care 24 hours a day in the hospice inpatient unit or in patients’ homes within the community hospice setting, which will include complex symptom management, end of life care, respite and assessment of a patient’s changing condition, under the care of a palliative care consultant physician and a multi professional team including nurses, social worker, carers’ support, complementary therapy, occupational therapy and spiritual care and a Bereavement Support Service. The Authority will observe a 10-day standstill from the date of publication of this VEAT, during which the Authority will not enter into any contractual arrangement. The Authority is yet to agree on the appropriate inflation and uplift for this contract for the period of 2022/23 and 2023/24. These will be dealt with as Contract Variations in accordance with the NHS Standard Contract Terms and Conditions. The Authority deems any such variations are not substantial or material changes, as they occur due to external causes beyond the Authority's control, including changes in contract value driven by changes in patient volume. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final. Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.

Award Detail

Award Criteria

CPV Codes

• 85100000 - Health services

Legal Justification

The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services. The Authority is currently in a transitional period with the expectation to be superseded as a statutory body, by an Integrated Care Board in late 2022. The organisation shall have a key function as part of the overall Integrated Care System. At the current time, longer-term strategies across all sectors are under discussion and longer term commissioning decisions and or procurements cannot take place until these legal arrangements are confirmed. The Authority has therefore taken a decision to award a contract to the incumbent provider to manage critical risks and ensure consistency in provision of care that meet the needs of the population. These Services have historically been provided under an NHS Grant Agreement, due to their nature but the Authority has decided to move these onto a contract to support clinical quality oversight and to align with other main two MSE Hospices. Additionally, the provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst transitioning to the ICB, because the NHS is contributing to the overall costs towards all of the services within the contract being delivered by the provider already, and so gets a return on investment. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded a under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The Contracting Authorities participating in the publication of this VEAT and the award of the contract communicated herein are: NHS Castle Point and Rochford Clinical Commissioning Group Pearl House, 12 Castle Road, Rayleigh. SS6 7QF https://castlepointandrochfordccg.nhs.uk/ NHS Southend Clinical Commissioning Group 6th Floor, Civic Centre, Victoria Avenue, Southend-on-Sea, SS1 9SB https://southendccg.nhs.uk/